All Blogs

Aug 01, 2025

In today's hyper-competitive and information-saturated global economy, companies across sectors are constantly challenged to make high-stakes decisions at speed and scale. Whether it's an established multinational corporation or a nimble start-up, navigating complexity often leads to operational delays, financial m...

Sep 07, 2021

Pfizer’s RSV Vaccine enters in the late-stage of clinical trials  As the battle to get an effective Respiratory Syncytial Virus (RSV) vaccine on the market heats up, Pfizer is launching a critical late-stage study of its experimental vaccine against a severe version of a cold virus that may cause pneumonia ...

Sep 06, 2021

Phenylketonuria is an inherited disorder characterized by the absence or deficiency of an enzyme called phenylalanine hydroxylase (PAH), responsible for processing the amino acid phenylalanine. The condition affects one in 13,500 to 19,000 newborns in the United States, says NORD. DelveInsight’s Phenylketonuria epi...

Sep 03, 2021

Charcot-Marie-Tooth (CMT) disease is a rare, chronic and sensory neuropathy that causes weakness of the limbs and progresses gradually over time. It can lead to atrophy, sensory loss and complete limb dysfunction. However, rare, the condition is the most common inherited disorder that damages peripheral nerves with...

Sep 02, 2021

FDA awards Breakthrough Device Designation to Impella ECP  On August 18, 2021, Abiomed received breakthrough device designation from the United States Food and Drug Administration (FDA) for its Impella ECP expandable percutaneous heart pump, the world’s smallest heart pump and the first to be compatible wit...

Sep 01, 2021

Drones, also referred to as unmanned aerial vehicles (UAVs)/unpiloted aircraft, are remotely piloted to meet various needs. Drones are one of the emerging technologies that are reshaping the transportation system. Earlier, the main use of drones was for a military expedition, however, today the drones can be seen i...

Aug 31, 2021

FDA's Green Flag to Ascendis's Once-Weekly SKYTROFA for Treatment of Pediatric Growth Hormone Deficiency For the treatment of growth failure due to deficiency of growth hormones, the USFDA approved Ascendis Pharma's Skytrofa (lonapegsomatropin-tcgd) for children of one year and older suffering from an improper s...

Aug 30, 2021

Venous thromboembolism (VTE) is a condition that is characterized by the development of blood clots in the veins. The condition includes Deep vein thrombosis (DVT) which occurs when a blood clot forms in a deep vein of the lower legs or pelvic area. However, in some cases, the blood clots from pelvic areas may brea...

Aug 20, 2024

Duchenne muscular dystrophy (DMD) is a rare genetic disorder usually diagnosed in young boys, gradually weakening muscles across the body until the heart or lungs fail. Symptoms often show up by the age of 5; as the disease progresses, patients tend to lose the ability to walk around the age of 12. As per a recent ...

Aug 26, 2021

Shape Therapeutics inks gene therapy deal with Roche worth up to USD 3 Billion Seattle biotech firm Shape Therapeutics has signed a deal potentially exceeding USD 3 billion with pharma giant Roche to bolster the development of gene therapies for Alzheimer’s and Parkinson’s disease. Shape’s RNA editing technol...